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Blockade of ERK Phosphorylation in the Nucleus Accumbens 
Inhibits the Expression of Cocaine-induced Behavioral Sensitization 
in Rats
Seungwoo Kim*†, Joong-Keun Shin*, Hyung Shin Yoon‡, and Jeong-Hoon Kim
Department of Physiology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Korea
  Repeated administration of psychostimulants such as cocaine leads to the development of behavioral 
sensitization. Extracellular signal-Regulated Kinase (ERK), an enzyme important for long-term 
neuronal plasticity, has been implicated in such effects of these drugs. Although the nucleus accumbens 
(NAcc) is the site mediating the expression of behavioral sensitization by drugs of abuse, the precise 
role of ERK activation in this site has not been determined. In this study we demonstrate that blockade 
of ERK phosphorylation in the NAcc by a single bilateral microinjections of PD98059 (0.5 or 2.0μg/ 
side), or U0126 (0.1 or 1.0μg/side), into this site dose-dependently inhibited the expression of 
cocaine-induced behavioral sensitization when measured at day 7 following 6 consecutive daily cocaine 
injections (15 mg/kg, i.p.). Acute microinjection of either vehicle or PD98059 alone produced no different 
locomotor activity compared to saline control. Further, microinjection of PD98059 (2.0μg/side) in the 
NAcc specifically lowered cocaine-induced increase of ERK phosphorylation levels in this site, while 
unaffecting p-38 protein levels. These results indicate that ERK activation in the NAcc is necessary 
for the expression of cocaine-induced behavioral sensitization, and further suggest that repeated cocaine 
evokes neuronal plasticity involving ERK pathway in this site leading to long-lasting behavioral 
changes.
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INTRODUCTION
  Repeated exposure to psychomotor stimulant drugs such 
as cocaine produces behavioral sensitization, which most 
often demonstrated in mouse and rats as a progressive and 
enduring augmentation of locomotor responses to the drug 
[1]. This phenomenon has been proposed to underlie the 
ability of psychomotor stimulants to elicit craving by en-
hancing the incentive motivational value of these drugs 
[2,3]. Thus, elucidating the molecular mechanisms that in-
volve in behavioral sensitization will provide a better un-
derstanding about the critical steps that mark the transi-
tional shift to compulsive drug use among human addicts.
  Extracellular signal-regulated kinase (ERK) is a protein 
serine/threonine kinase that plays an important role in var-
ious types of neuronal adaptive responses as well as in 
learning and memory [4,5]. Several lines of evidence in-
dicate that ERK pathway also importantly involves in both 
acute and long-term adaptive processes by drugs of abuse. 
For example, chronic administration of cocaine or morphine 
increases ERK activity in the ventral tegmental area 
(VTA), the region in the ventral midbrain that contains dop-
aminergic cell bodies [6]. In the nucleus accumbens (NAcc), 
which receives dopaminergic axonal projections from the 
VTA, ERK activation is induced by acute cocaine [7] and 
it is augmented in cocaine-sensitized rats [8]. Behavioral 
studies also show that the systemic injection of SL327, a 
selective inhibitor of ERK kinase (MEK), abolishes the de-
velopment of locomotor sensitization as well as conditioned 
place preference by cocaine [7,9].
  Evidence indicates that the development of behavioral 
sensitization is initiated in the VTA, while its expression 
is due to drug actions in the NAcc [10,11]. Recent research 
shows that the development of sensitization to cocaine was 
prevented by pre-treatment of a MEK inhibitor prior to 
each drug administration during the induction phase [9,12], 
while its expression was not affected when challenged later 
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with cocaine in the presence of the same inhibitor [9]. 
However, these results were all obtained with systemic in-
jections of a MEK inhibitor SL327, which crosses the 
blood-brain barrier and affects various brain regions (for 
example, see [9]), so that it was not clear in which area 
of brain ERK actually contributes to sensitization. Al-
though it was previously observed that the initiation of be-
havioral sensitization to cocaine was blocked by intra-VTA 
microinjection of another MEK inhibitor PD98059 [13], the 
role of ERK in the expression of sensitization has not been 
examined yet directly in the NAcc. Thus, we investigated 
in the present study whether a specific blockade of ERK 
phosphorylation by microinjection of PD98059 into the 
NAcc produces a differential effect to the expression of be-
havioral sensitization to cocaine.
METHODS
Animals and surgery
  Male Sprague-Dawley rats weighing 220∼250 g on arriv-
al were obtained from Orient Bio Inc. (Seongnam-si, Korea). 
They were housed three per cage in a 12-hr light/dark cycle 
room with food and water available at all times. All animal 
use procedures were conducted according to an approved 
IACUC protocol. Rats were anesthetized with intraperi-
toneal (IP) ketamine (100 mg/kg) and xylazine (6 mg/kg), 
placed in a stereotaxic instrument with the incisor bar at 
5.0 mm above the interaural line and implanted with chron-
ic bilateral guide cannulas (22 gauge; Plastics One, 
Roanoke, VA) aimed at the NAcc (A/P, ＋3.4; L, ±1.5; D/V, 
−7.5 mm from bregma and skull) [14]. Cannulas were an-
gled at 10o to the vertical, positioned 1 mm above the final 
injection site, and secured with dental acrylic cement anch-
ored to stainless steel screws fixed to the skull. After sur-
gery, 28 gauge obturators were placed in the guide cannu-
las, and rats were returned to their home cages for a 7-day 
recovery period.
Drugs and intracranial microinjections
  PD98059 and U0126 (Sigma, St. Louis, MO) were dis-
solved in 70% and 20% DMSO, respectively, and small ali-
quots were stored at −20oC. Immediately before use, frozen 
aliquots of each drug were diluted to concentrations of ei-
ther 1.0 or 4.0μg/μl in 70% DMSO (PD98059) and of either 
0.2 or 2.0μg/μl in 20% DMSO (U0126). Cocaine hydro-
chloride (Belgopia, Belgium) was dissolved in sterile 0.9% 
saline. Bilateral intracranial microinjections into the NAcc 
were made in the freely moving rat. Injection cannulas (28 
gauge) connected to 1μl syringes (Hamilton, Reno, NV) via 
PE-20 tubing were inserted to a depth 1 mm below the 
guide cannula tips. Injections were made in a volume of 
0.5μl per side over 30 sec. After 1 min, the injection cannu-
las were withdrawn and the obturators were replaced.
Locomotor activity
  Locomotor activity was measured in a bank of 6 activity 
boxes (35×25×40 cm) (IWOO Scientific Corporation, Seoul, 
Korea) made of translucent Plexiglas and individually kept 
in larger PVC plastic sound attenuating cubicles. The floor 
of each box consisted of 21 stainless steel rods (5 mm diame-
ter) spaced 1.2 cm apart center-to-center. Locomotor activ-
ity was counted by two infrared light photocells (Med 
Associates, Inc., St. Albans, VT, USA), positioned 4.5 cm 
above the floor and spaced evenly along the longitudinal 
axis of each box.
Design and procedure
  Experiment 1: Six different groups of rats were randomly 
assigned and half of them were administered once a day 
with saline and the other half with cocaine (15 mg/kg, IP) 
for 6 consecutive days. Injections were made in the activity 
boxes on day 1 and 6, and at home-cages for the rest of 
days (day 2 to 5). On day 7, animals were first habituated 
to the activity boxes for 1 hour, then microinjected bi-
laterally into the NAcc with either vehicle (70% DMSO) or 
each dose of PD98059 (0.5 and 2.0μg/0.5μl/side). Microin-
jections were performed only a single time and animals re-
mained in the activity boxes for further 30 min until they 
were all cocaine (15 mg/kg, IP) challenged, then their loco-
motor activity was measured for 2 hours.
  Additional four groups of drug-naïve rats were first habi-
tuated to the activity boxes for 1 hour, then microinjected 
only a single time with either saline or vehicle, one of two 
doses of PD98059 (0.5, 2.0μg/side) and remained in the ac-
tivity boxes for 30 min. Then, they were all saline (IP) chal-
lenged and their locomotor activity measured for 1 hour.
  Experiment 2: Four different groups of rats were ran-
domly assigned and half of them were microinjected with 
vehicle and the other half with a single dose of PD98059 
(2.0μg/side). Then, each group was subdivided into two and 
administered with either saline or cocaine (15 mg/kg, IP), 
respectively. Animals were decapitated 10 min after saline 
or cocaine IP injection, brains were rapidly removed and 
coronal sections (1.0 mm thick extending 1.60∼2.60 mm 
from bregma) were obtained with an ice-cold brain slicer. 
Tissue punches (1.2 mm diameter) were obtained in both 
the NAcc region (covering most medial part of the core and 
some portion of the shell near the border of the two) and 
the dorsal striatum on an ice-cold plate, immediately frozen 
on dry ice and stored at −80oC. They were prepared bi-
laterally and pooled for each individual animal’s protein 
isolation.
  Experiment 3: Six different groups of rats were randomly 
assigned and half of them were administered once a day 
with saline and the other half with cocaine (15 mg/kg, IP) 
for 6 consecutive days. Injections were made in the activity 
boxes on day 1 and 6, and at home-cages for the rest of 
days (day 2 to 5). On day 7, animals were first habituated 
to the activity boxes for 1 hour, then microinjected bi-
laterally into the NAcc with either vehicle (20% DMSO) or 
each dose of U0126 (0.1 and 1.0μg/0.5μl/side). Microinjec-
tions were performed only a single time and animals re-
mained in the activity boxes for further 30 min until they 
were all cocaine (15 mg/kg, IP) challenged, then their loco-
motor activity was measured for 1 hour.
Western blotting
  Tissues were homogenized in lysis buffer containing 0.32 
M sucrose, 2 mM EDTA, 1% SDS, 10μg/ml aprotinin, 10 
μg/ml leupeptin, and 1mM phenylmethylsulfonyl fluoride. 
The concentration of protein was determined by using 
Pierce BCA protein assay kit (Pierce, Rockford, IL). Sam-
ples were then boiled for 10 min and subjected to SDS-poly-
acrylamide gel electrophoresis. Proteins were transferred 
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Fig. 1. Blockade of ERK phosphorylation by a single microinjection of PD98059 in the NAcc inhibits the expression of cocaine-induced 
locomotor sensitization. (A) Animals were either saline or cocaine pre-exposed for 6 days. At day 7, their locomotor activity was observed 
after cocaine (15 mg/kg, IP) challenge injections preceded 30 min earlier by an acute single bilateral microinjection of either vehicle or 
PD98059 (0.5, 2.0μg/side) into the NAcc. Enhanced increase of locomotor activity in cocaine compared to saline pre-exposed animals was 
dose-dependently inhibited by PD98059 microinjection into the NAcc. Data are shown as group mean (＋S.E.M.) total locomotor activity 
counts observed during the first 1 hour. Numbers of rats in each group are 6∼7. Symbols indicate significant differences as revealed 
by post-hoc Scheffé comparisons following two-way between (microinjections) - within (pre-exposures) ANOVA. ***p＜0.001, **p＜0.01; 
significantly more counts in cocaine relative to saline pre-exposed animals. ††p＜0.01; significant differences in cocaine pre-exposed animals
when PD98059 (2.0μg/side) compared to vehicle was microinjected. (B) Time-course data are shown as group mean (＋S.E.M.) locomotion 
activity counts for every 20 min time-bins obtained during the 2-hr test immediately after cocaine challenge injection. (C) Location of 
the microinjection cannula tips in the NAcc of rats included in the data analyses. Only rats with injection cannula tips located bilaterally 
in this site were included. No neuronal damage was observed other than that produced by the insertion of the cannulae. The line drawings
are from Paxinos and Watson [15]. Numbers to the right indicate millimeters from bregma.
electrophoretically to nitrocellulose membranes (Bio-Rad, 
Hercules, CA), which were then blocked with 5% skim milk 
in PBS-T buffer [10 mM phosphate-buffered saline plus 
0.05% Tween-20]. Specific antibodies against phospho-ERK 
1/2, phospho-p38 (1：1,000 dilution in PBS-T with 5% bo-
vine serum albumin; Cell Signaling, Beverly, MA) and 
ERK1/2, p38 (1：1,000 dilution in PBS-T with 5% skim 
milk; Cell Signaling) kinases were used to probe the blots. 
Primary antibodies were detected with peroxidase-con-
jugated secondary antibodies (1：2,000 dilution in PBS-T 
with 5% skim milk; KOMA Biotech, Seoul, Korea) followed 
by enhanced chemiluminescence (ECL) reagents (Amers-
ham Biosciences, Arlington Heights, IL) and exposure to 
X-ray film. Band intensities were quantified based on den-
sitometric values using Fujifilm Science Lab 97 Image 
Gauge software (version 2.54). Antibodies on the membrane 
were removed by using RestoreTM Western Blot Stripping 
Buffer (Pierce, Rockford, IL, USA) and re-probed with anti-
β-actin antibody (1：10,000 dilution in PBS-T with 5% 
skim milk; Abcam, Cambridge, UK).
Histology
  After completion of behavioral experiments, animals 
were anesthetized and perfused via intracardiac infusion 
of saline and 10% formalin. Brains were removed and fur-
ther post-fixed in 10% formalin. Coronal sections (40μm) 
were subsequently stained with cresyl violet for verification 
of cannula tip placements. Only rats with injection cannula 
tips located bilaterally in correct placements were included: 
a total of 117 rats (38, 20, 30 and 29 for Fig. 1∼4, re-
spectively) out of 135 initially prepared.
RESULTS
Blockade of ERK phosphorylation by a single micro-
injection of PD98059 in the NAcc inhibits the express-
ion of cocaine-induced locomotor sensitization
  Fig. 1A shows the locomotor activity counts obtained in 
both saline and cocaine pre-exposed rats in response to an 
IP cocaine challenge injection following a single NAcc mi-
croinjection of either vehicle or each dose of PD98059 (0.5 
and 2.0μg/side). The two-way between (microinjections) - 
within (pre-exposures) ANOVA conducted on these data 
found an approached significance for different micro-
injections [F2,32=2.95, p＜0.068] and multiple significant ef-
fects of different pre-exposures [F1,32=35.34, p＜0.001], and 
a microinjections X pre-exposures interaction [F2,32=3.71, p
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Fig. 3. PD98059 in the NAcc lowers cocaine-induced increase of ERK phosphorylation levels in this site. Animals were either saline or 
cocaine (15 mg/kg) IP challenged following 30 min earlier microinjection of either vehicle or a single dose of PD98059 (2.0 μg/side). After 
10 min, brains were removed and the NAcc tissues were punched out. Representative Western blots labeled with antibodies against 
phosphorylated and total ERK1/2 (A), and p-38 (B), were shown. Blots were scanned and the band intensities were quantified using 
densitometer. Values are normalized to β-actin and expressed as mean (＋S.E.M.) (n=7 to 8/group) transformed to relative amounts of 
control (vehicle microinjection - saline IP) values. Symbols indicate significant differences as revealed by post-hoc Scheffé comparisons 
following two-way between (IP challenges) - within (microinjections) ANOVA. **p＜0.01; significantly higher levels of p-ERK1/2 in cocaine
relative to saline challenged animals. ††p＜0.01; significant differences in cocaine challenged animals when PD98059 (2.0μg/side) compared 
to vehicle was microinjected. Other proteins examined showed no differences between groups.
Fig. 2. Acute microinjection of vehicle or PD98059 alone into the 
NAcc produces no different levels of locomotor activity compared 
to saline control. Locomotor activity is observed after saline (IP) 
injections following bilateral microinjections of either saline or 
vehicle (70% DMSO), PD98059 (0.5, 2.0μg/side) into the NAcc. 
Data are shown as group mean (＋S.E.M.) total locomotor activity 
counts observed for 1 hour (n=5/group).
＜0.037]. As expected, daily cocaine pre-exposed rats com-
pared to saline showed a sensitized locomotor activity in 
response to an IP cocaine challenge injection when vehicle 
was microinjected into the NAcc (p＜0.001, by post-hoc 
Scheffé comparisons). This effect of cocaine, however, was 
inhibited in a dose-dependent manner by a single micro-
injection into the NAcc of PD98059 (p＜0.01 in a high dose, 
2.0μg/side, compared to vehicle). In saline pre-exposed 
rats, PD98059 had no effect on locomotor activity in re-
sponse to a cocaine challenge indicating that NAcc micro-
injection of PD98059 produces its effect on sensitized rather 
than acute locomotor activity by cocaine. The time-course 
data and location of injection cannula tips in the NAcc of 
rats that were included in this experiment are illustrated 
in Fig. 1B and C, respectively.
Acute microinjection of vehicle or PD98059 alone into 
the NAcc produces no different levels of locomotor 
activity compared to saline control
  To further examine the specific ability of NAcc PD98059 
to inhibit the expression of locomotor sensitization to co-
caine, additional rats were just acute saline challenged fol-
lowing microinjection of either vehicle or PD98059 and 
their locomotor activity were measured (Fig. 2). The one- 
way ANOVA conducted on these data found no significant 
differences between groups [F3,16=0.07, p＜0.976], indicat-
ing that either vehicle or any dose of PD98059 used in the 
present experiments does not produce the change of basal 
locomotor activity consistent with previous findings [16].
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Fig. 4. Blockade of ERK phosphorylation by a single microinjection
of U0126 in the NAcc inhibits the expression of cocaine-induced 
locomotor sensitization. Animals were either saline or cocaine 
pre-exposed for 6 days. At day 7, their locomotor activity was 
observed after cocaine (15 mg/kg, IP) challenge injections preceded 
30 min earlier by acute bilateral microinjections of either vehicle 
or U0126 (0.1, 1.0μg/side) into the NAcc. Enhanced increase of 
locomotor activity in cocaine compared to saline pre-exposed 
animals was dose-dependently inhibited by a single U0126 micro-
injection into the NAcc. Data are shown as group mean (＋S.E.M.) 
total locomotor activity counts observed during the 1 hour. 
Numbers of rats in each group are 4∼6. Symbols indicate signi-
ficant differences as revealed by post-hoc Scheffé comparisons 
following two-way between (microinjections) - within (pre-exposures) 
ANOVA. **p＜0.01; significantly more counts in cocaine relative to 
saline pre-exposed animals. †p＜0.05; significant differences in 
cocaine pre-exposed animals when U0126 (1.0μg/side) compared 
to vehicle was microinjected.
PD98059 in the NAcc lowers cocaine-induced increase 
of ERK phosphorylation levels in this site
  Because we used microinjection techniques, in order to 
confirm the ability of PD98059 to lower phosphorylated 
ERK1/2 levels directly in the tissue, both the NAcc and dor-
sal striatum were taken out from the animals either saline 
or cocaine IP injected following microinjection of either ve-
hicle or a high dose of PD98059 and their protein levels 
were analyzed (Fig. 3). Either phosphorylated (pERK1/2 
and p-p38) or total (ERK1/2 and p38) protein kinase levels 
were examined on separate gels and normalized to β-actin 
protein levels. The 42- and 44-kDa forms of ERK were 
quantified together. The increased levels of phosphorylated 
ERK1/2 by cocaine in the NAcc were significantly lowered 
in PD98059 (2.0μg/side)- compared to vehicle-micro-
injected animals as revealed by post-hoc Scheffé compar-
isons (p＜0.01) following two-way between (IP challenges) - 
within (microinjections) ANOVA (for microinjections [F1,26 
=4.03, p＜0.055], IP challenges [F1,26=4.33, p＜0.047], and 
a microinjections X IP challenges interaction [F1,26=4.60, p
＜0.042]). Total ERK1/2 and both phosphorylated and total 
p38 levels showed no differences between groups. All pro-
tein levels examined in dorsal striatum were unaffected by 
PD98059 microinjection into the NAcc (data not shown). 
These results clearly indicate that microinjection of PD98059 
into the NAcc selectively lowers ERK phosphorylation lev-
els only in this site.
Blockade of ERK phosphorylation by a single micro-
injection of U0126 in the NAcc inhibits the expression 
of cocaine-induced locomotor sensitization
  Finally, we further examined the specific ability of p-ERK 
blockade in the NAcc on the inhibition of the expression 
of locomotor sensitization to cocaine by using another MEK 
inhibitor, U0126. Fig. 4 shows the locomotor activity counts 
obtained in both saline and cocaine pre-exposed rats in re-
sponse to an IP cocaine challenge injection following a sin-
gle NAcc pre-infusion of either vehicle or each dose of 
U0126 (0.1 and 1.0μg/side). The two-way between (micro-
injections) - within (pre-exposures) ANOVA conducted on 
these data found a significant effect of different pre-ex-
posures [F1,23=6.90, p＜0.016]. Again, rats pre-exposed to 
daily cocaine compared to saline showed a sensitized loco-
motor activity in response to an IP cocaine challenge in-
jection when vehicle was microinjected into the NAcc (p
＜0.01, by post-hoc Scheffé comparisons). However, this ef-
fect of cocaine, similar to PD98059, was inhibited in a 
dose-dependent manner by a single microinjection into the 
NAcc of U0126 (p＜0.01 in a high dose, 1.0μg/side, com-
pared to vehicle). In saline pre-exposed rats, U0126 had no 
effect on locomotor activity in response to a cocaine chal-
lenge indicating that NAcc microinjection of U0126 also 
produces its effect on sensitized rather than acute locomo-
tor activity by cocaine.
DISCUSSION
  The present results are the first demonstration, to our 
knowledge, that a direct bilateral microinjection into the 
NAcc of PD98059, or U0126, MEK inhibitors, dose-depend-
ently inhibits the expression of cocaine-induced behavioral 
sensitization. This effect was clearly observed when chal-
lenged by cocaine following the acute single microinjection 
of PD98059, or U0126, in cocaine pre-exposed animals, 
while it was not in saline pre-exposed. Further, micro-
injection of PD98059 into the NAcc produced no effect on 
the basal locomotor activity, while it specifically lowered 
cocaine-induced increase of phosphorylated ERK levels in 
this site. These results illustrate the importance of ERK 
activation in the NAcc for the expression of cocaine-induced 
behavioral sensitization.
  It has recently been shown that the development of sensi-
tization to cocaine is prevented by systemic pre-treatment 
of a MEK inhibitor, SL327, prior to each drug admin-
istration during the induction phase [9,12]. These effects 
were further supported by earlier results that the initiation 
of behavioral sensitization to cocaine was blocked by in-
tra-VTA microinjection of another MEK inhibitor, PD98059 
[13]. These results indicate that consistent ERK activation, 
especially in the VTA, during the induction phase is neces-
sary for the development of behavioral sensitization by 
cocaine. However, the role of ERK activation in the ex-
pression of behavioral sensitization, which is mediated 
through a different neuronal substrate (i.e., the NAcc) 
[10,11], remained undefined. Although recent results also 
showed that the blockade of ERK pathway did not alter 
the expression of behavioral sensitization to cocaine and 
amphetamine [9], these results were all obtained with sys-
temic injections of SL327. This drug crosses the blood-brain 
barrier and reduced ERK phosphorylation levels in various 
brain regions [9], which thereby makes it unclear whether 
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the NAcc ERK actually contributes to the expression of be-
havioral sensitization to psychomotor stimulants. In the 
present results, we used a single direct microinjection into 
the NAcc of different types of MEK inhibitors, PD98059, 
or U0126, and found that ERK activation specifically in this 
site is actually necessary for the expression of behavioral 
sensitization. The NAcc exists as a central part of a compli-
cated neuronal circuit mediating rewarding and motor be-
haviors and its activity is regulated by signals coming from 
other brain regions. The difference in our results compared 
from previous findings that SL327 have no effect on the 
expression of behavioral sensitization may have come out 
because we inhibited ERK phosphorylation directly in the 
NAcc, whereas others inhibited it simultaneously in many 
brain regions causing its effect in the NAcc to be compro-
mised by signals coming from other regions.
  The delivery vehicle we used for MEK inhibitors was 
DMSO. Microinjection of this vehicle alone (up to 70% for 
PD98059) compared to saline didn’t affect basal locomotor 
activity in response to IP saline injection. Similar to and 
consistent with our findings, others have also reported that 
various dose ranges (50∼100%) of DMSO were micro-
injected into the NAcc as well as into the VTA without evi-
dent disturbances of locomotor activity and neuronal dam-
age [8,13,16]. Our present results also showed that micro-
injection into the NAcc of PD98059 had no effect on the 
locomotor activity produced by either acute cocaine (saline 
pre-exposed and cocaine challenged in Fig. 1A) or saline 
injection (Fig. 2). These results indicate that the inhibitory 
effect of PD98059 was rather specific to the expression of 
locomotor sensitization to cocaine and further support and 
extend its role in the regulation of neuronal plasticity in-
duced by drugs of abuse found in various aspect of addiction 
[8,9,12,16,17].
  It has been reported that the levels of ERK phosphor-
ylation in the NAcc increased by cocaine challenge [8,18]. 
In order to verify that this increase of cocaine-induced ERK 
phosphorylation levels is actually lowered by our micro-
injection procedure, we measured protein levels in both the 
NAcc and dorsal striatum after either vehicle or PD98059 
microinjection. Although a recent finding using knockout 
mice suggests that ERK 1 and 2 may have different roles 
in cocaine-induced plasticity [12], it remains to be further 
explored, so that we decided in the present experiments to 
quantify both proteins together. As shown in Fig. 3, our 
microinjection procedure specifically lowered cocaine-in-
duced increase of phosphorylated ERK1/2 levels in the 
NAcc, but not affected the levels of total ERK1/2 and anoth-
er MAP kinase p38, both phosphorylated and total. These 
effects were not observed in dorsal striatum (data not 
shown). These results support that our behavioral findings 
were actually obtained correlated with the specific blockade 
of ERK phosphorylation in the NAcc and further suggest 
that specific ERK activation in this site may play an im-
portant role in neuronal plasticity contributing to the ex-
pression of sensitization.
  Evidence shows that the interaction of both dopamine 
and glutamate in the NAcc is necessary for the expression 
of behavioral sensitization by psychomotor stimulants 
[19-21] and previous exposure to psychomotor stimulants 
increases dopamine and glutamate overflows in the NAcc 
[22,23]. Interestingly, it has been shown that cocaine-in-
duced ERK activation is also dependent on both dopamine 
and glutamate activation probably via DARPP-32 mediated 
signaling pathways [7,18,24]. Together with our present 
findings, this leads to the hypothesis that the increase of 
dopamine and glutamate levels by cocaine challenge may 
subsequently result in increase of ERK phosphorylation, 
and thereby contributes to the expression of behavioral 
sensitization. However, it remains to be further explored. 
  Finally, in the present experiments, most microinjections 
of PD98059 were made into the core of the NAcc. However, 
in consideration with the increasing knowledge of the dif-
ferential involvement in addiction-related behaviors of the 
two sub-regions, core and shell, of the NAcc [25,26], a more 
thorough systematic assessment of the effects of PD98059 
in these different sub-regions of the NAcc is in order.
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